{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-018380","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2023-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.746405+00:00","generated_at":"2026-06-14T20:31:31.253216+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Oncotelic adopts new bylaws with advance notice provisions for shareholder proposals.","bullets":["Board adopted new amended and restated bylaws on May 18, 2023.","New bylaws add advance notice requirements for shareholder proposals at meetings or consent solicitations.","Replaces prior bylaws; full text filed as Exhibit 3.2.","No financial or operational changes reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-018380","json":"https://secwatch.observer/filing/0001493152-23-018380.json","markdown":"https://secwatch.observer/filing/0001493152-23-018380.md","text":"https://secwatch.observer/filing/0001493152-23-018380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315223018380/0001493152-23-018380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315223018380/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T20:31:31.253216+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f2a827b4e122fc5b07b4be0babaac1be39ec2415","claim":"Oncotelic Therapeutics, Inc.: Adopted new amended and restated by-laws containing new advance notice provisions for shareholder proposals and consent solicitations (effective 2023-05-18).","evidence_excerpt":"On May 18, 2023, the Board of Directors of Oncotelic Therapeutics, Inc. (the “ Company ”) adopted the new amended and restated by-laws (the “ New By-Laws ”) for the Company, replacing the prior amended and restated by-laws. The New By-Laws contain new provisions for advance notices by shareholders to propose items for consideration at future Annual Meetings or Consent Solicitations.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/908259/000149315223018380/0001493152-23-018380-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-05-18"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}